Horizon Technology Finance Corporation Provides $45MM Term Loan to Evelo Biosciences
Evelo Biosciences, a clinical stage biotechnology company, entered into a senior secured loan agreement with Horizon Technology Finance Corporation. The $45 million term loan replaces the company’s existing senior secured debt.
December 19, 2022
Evelo Biosciences | Gerald A. Michaud | Horizon Technology Finance Corporation | Marella Thorell
Ian Koplin